Plasma-to-RBC ratio category | Non-geriatric group | Geriatric group | ||||
---|---|---|---|---|---|---|
n | Age: 16–64 years | p | n | Age: ≥ 65 years | p | |
OR (95% CI) | OR (95% CI) | |||||
In-hospital mortality | Â | Â | Â | Â | Â | |
 Low | 4239 | 1.38 (1.22–1.56) |  < 0.001 | 642 | 0.84 (0.62–1.12) | 0.233 |
 Medium | 6938 | 1.00 [Reference] |  | 897 | 1.00 [Reference] |  |
 High | 1064 | 1.21 (0.98–1.49) | 0.149 | 114 | 1.34 (0.80–2.27) | 0.276 |
24-h mortality | Â | Â | Â | Â | Â | Â |
 Low | 4239 | 1.75 (1.50–2.00) |  < 0.001 | 642 | 1.11 (0.79–1.55) | 0.522 |
 Medium | 6938 | 1.00 [Reference] |  | 897 | 1.00 [Reference] |  |
 High | 1064 | 0.92 (0.71–1.18) | 0.57 | 114 | 0.85 (0.42–1.63) | 0.657 |
Adverse events | Â | Â | Â | Â | Â | Â |
 Low | 4239 | 0.70 (0.62–0.80) |  < 0.001 | 642 | 0.6 (0.43–0.84) | 0.002 |
 Medium | 6938 | 1.00 [Reference] |  | 897 | 1.00 [Reference] |  |
 High | 1064 | 1.16 (0.96–1.39) | 0.111 | 114 | 0.79 (0.43–1.40) | 0.438 |